Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Almac Group
Almac Group
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
G-CON launches "floorlessPOD" prefabricated cleanroom
The global cleanroom provider has launched its newest innovative prefabricated cleanroom structure that comes without an integrated floor
Thermo Fisher Scientific opens sterile drug facility in Asia
The global company has built a new manufacturing facility and expanded capabilities in Singapore to enable the country’s science and technology sector to accelerate research,...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Manufacturing
Almac Group launches new addition to temperature management service
Tempod 1000 has been created to improve clinical site temperature data management as manual methods of data capture have proved challenging due to disruptions caused by the global pandemic
Almac Discover appoints new VP of BD & Licensing
Dr Alan Lamont will report to Managing Director & President, Dr Stephen Barr
Manufacturing
Almac Group appoints Dr Sheryl Foster as Vice President of Quality
Estates & Facilities
Almac Group extends personalised cancer vaccine production facilities
The pharmaceutical CDMO will be investing in new labs and office spaces
Pharmaceutical
Galen appoints Dr Dennise Broderick as Managing Director
Manufacturing
Almac Group launches second line for high throughput GMP Peptide
Based in Edinburgh, Scotland, the facility manufactures neoantigen derived peptides for use in the production of patient specific, individualised cancer vaccines
Regulatory
Almac passes HSA inspection of Asia Pacific operation
The British CDMO has received renewal of the GMP/GDP certification of its Singapore facility from the Health Sciences Authority
Subscribe now